ES2131530T3 - Antagonistas del factor de activacion de las plaquetas. - Google Patents

Antagonistas del factor de activacion de las plaquetas.

Info

Publication number
ES2131530T3
ES2131530T3 ES92915895T ES92915895T ES2131530T3 ES 2131530 T3 ES2131530 T3 ES 2131530T3 ES 92915895 T ES92915895 T ES 92915895T ES 92915895 T ES92915895 T ES 92915895T ES 2131530 T3 ES2131530 T3 ES 2131530T3
Authority
ES
Spain
Prior art keywords
pct
pyrrolo
pyridin
carbonyl
paf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915895T
Other languages
English (en)
Inventor
James B Summers
Steven K Davidsen
James H Holms
Daisy Pireh
H Robin Heyman
Michael B Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2131530T3 publication Critical patent/ES2131530T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

COMPUESTOS DE INDOLA SUSTITUIDOS EN LA POSICION 3 POR 7CARBONIL(PIRIDIN-3-IL)PIRROLO[1,2-C]TIAZOLA, 7-CARBONIL(PIRIDIN-3IL)PIRROLO[1,2-C]OXAZOLINA, O 7-CARBONIL(PIRIDIN-3-IL)PIRROLO[1,2C]PIRROLA SON ANTAGONISTAS POTENTES DEL PAF Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS DEL PAF INCLUYENDO EL ASMA, SINDROME DE ANGUSTIA RESPIRATORIA, INFLAMACION AGUDA, RECHAZO DE ORGANOS TRASPLANTADOS, ULCERA GASTROINTESTINAL, ENFERMEDADES ALERGICAS DE LA PIEL, INMUNIDAD CELULAR RETARDADA, PARTO, MADURACION DE PULMON FETAL Y DIFERENCIACION CELULAR.
ES92915895T 1991-07-17 1992-07-14 Antagonistas del factor de activacion de las plaquetas. Expired - Lifetime ES2131530T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73168191A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
ES2131530T3 true ES2131530T3 (es) 1999-08-01

Family

ID=24940541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915895T Expired - Lifetime ES2131530T3 (es) 1991-07-17 1992-07-14 Antagonistas del factor de activacion de las plaquetas.

Country Status (15)

Country Link
US (1) US5459152A (es)
EP (1) EP0595924B1 (es)
JP (1) JP3135917B2 (es)
KR (1) KR100251603B1 (es)
AT (1) ATE178796T1 (es)
AU (1) AU651243B2 (es)
CA (1) CA2112562A1 (es)
DE (1) DE69228932T2 (es)
DK (1) DK0595924T3 (es)
ES (1) ES2131530T3 (es)
GR (1) GR3030208T3 (es)
IE (1) IE922293A1 (es)
IL (1) IL102494A0 (es)
PT (1) PT100698B (es)
WO (1) WO1993001813A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6534535B1 (en) 1999-08-12 2003-03-18 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
US20130178453A1 (en) * 2010-02-09 2013-07-11 Ironwood Pharmaceuticals, Inc. Cannabinoid Agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2617484B1 (fr) * 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre
FR2626004B1 (fr) * 1988-01-20 1991-08-02 Rhone Poulenc Sante Procede de preparation du (pyridyl-3)-3 1h, 3h-pyrrolo (1,2-c) thiazolecarbonitrile-7
JP3061631B2 (ja) * 1989-10-11 2000-07-10 山之内製薬株式会社 新規なヘテロ環化合物およびその製造法

Also Published As

Publication number Publication date
GR3030208T3 (en) 1999-08-31
KR100251603B1 (ko) 2000-05-01
IL102494A0 (en) 1993-01-14
EP0595924A4 (en) 1994-08-24
IE922293A1 (en) 1993-01-27
CA2112562A1 (en) 1993-02-04
DK0595924T3 (da) 1999-11-01
DE69228932T2 (de) 1999-11-11
EP0595924B1 (en) 1999-04-14
JPH06510027A (ja) 1994-11-10
WO1993001813A1 (en) 1993-02-04
DE69228932D1 (de) 1999-05-20
PT100698A (pt) 1993-10-29
AU2339192A (en) 1993-02-23
EP0595924A1 (en) 1994-05-11
ATE178796T1 (de) 1999-04-15
AU651243B2 (en) 1994-07-14
JP3135917B2 (ja) 2001-02-19
US5459152A (en) 1995-10-17
PT100698B (pt) 1999-07-30

Similar Documents

Publication Publication Date Title
IL111963A0 (en) Platelet activating factor antagonists: imidazopyridine indoles
ES2164240T3 (es) Derivados de indol-3-carbonilo y 3-indol-3-sulfonilo como antagonistas del factor activante de plaquetas.
IL93508A0 (en) Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
FI20115753A (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
ES2131530T3 (es) Antagonistas del factor de activacion de las plaquetas.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
DE3782346D1 (de) Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln.
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
IT8948186A0 (it) Bocchino con filtro per sigarette atto ad eliminare il vizio del fumo
YU47013B (sh) Postupak za dobijanje supstituisanih pirimidina
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
EP0122155A3 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
IT1244725B (it) 1-b-ribofuranosil-pirazol-derivati e relativo processo di produzione e impiego farmacologico
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
ATA102377A (de) Verfahren zur herstellung von neuen derivaten des thiazolo (3,4-b) isochinolins und von ihren salzen
IT1127740B (it) Struttura di coppa ornata e procedimento per la produzione delle stesse
IT8019044A0 (it) Derivati di acidi carbossilici conproprieta'terapeutiche per il trattamento di malattie coronariche, della arteriosclerosi e di forme infiammatorie
PL288352A1 (en) Method of obtaining bisindole alkaloids exhibiting cytostatic effect
DE9307116U1 (de) Verfestigter Arzneistoffvorrat für die mechanische Erzeugung inhalierbarer Wirkstoffpartikel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595924

Country of ref document: ES